naltrexone and semaglutide glp-1 GLP-1s linked to lower rates of anxiety depression than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment exclude discount Color:Lavender GLP-1 Updates 2024 |

naltrexone and semaglutide glp-1 GLP-1s linked to lower rates of anxiety depression than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment exclude discount Color:Lavender GLP-1 Updates 2024 |

GLP-1 Updates 2024 | Innovative Rx Strategies

There’s a big footnote for this trial that takes us back to the Bhaumik award and why there was such a long time before the realization the GLP-1 drugs could be useful for obesity—people with diabetes on GLP-1 drugs didn’t lose much weight

exclude discount

Color:Lavender

Methodologies, limitations, and citations are also available in the full report